Similarly, the expression of CD133 and CD44 was greatly reduced in the GRP78-exos/anti-miR-769-5p group, and then enhanced after transfection of miR-769-5p mimics in CRC cells (Fig. 5D). This evidence concerns the gene CD44 and colorectal carcinoma.